Mulmit

NEUROCRINE BIOSCIENCES INCNEUROCRINE BIOSCIENCES INC

NBIX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-312,860,500,000619,100,000478,600,0004.67
2024-12-312,355,300,000570,500,000341,300,0003.29
2023-12-311,887,100,000250,900,000249,700,0002.47
2022-12-311,488,700,000249,000,000154,500,0001.56
2021-12-311,133,500,000102,500,00089,600,0000.92

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-02SHERWIN STEPHEN A1,000
2026-08-04Onyia JudeChief Scientific Officer2,409
2026-07-29Norwalk Leslie V842
2026-07-29Norwalk Leslie V842
2026-07-28Norwalk Leslie V1,250
2026-07-10Delaet IngridChief Regulatory Officer4,367
2026-07-10Delaet IngridChief Regulatory Officer4,367
2026-07-10Delaet IngridChief Regulatory Officer4,367
2026-07-09Lippoldt DarinChief Legal Officer10,000
2026-07-09Lippoldt DarinChief Legal Officer10,000
2026-07-09Lippoldt DarinChief Legal Officer10,000
2026-07-09Delaet IngridChief Regulatory Officer8,433

8-K events

FiledItems
2026-07-31Financial statements and exhibits
2026-07-30Results of operations · Financial statements and exhibits
2026-05-28Officer or director change · Submission of matters to a vote
2026-05-18Entry into a material agreement · Completed acquisition or disposition of assets · Creation of a direct financial obligation · Regulation FD disclosure · Financial statements and exhibits
2026-05-05Results of operations · Financial statements and exhibits
2026-04-06Entry into a material agreement · Financial statements and exhibits
2026-02-11Results of operations · Financial statements and exhibits
2025-11-24Officer or director change · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.